The Penn PET Addiction Center of Excellence is funded by a five-year, $8.9 million grant from the National Institute on Drug Abuse. It will be led by researchers from the University of Pennsylvania’s radiology and psychiatry departments and Center for Studies of Addiction, and from New Haven, Conn.-based Yale University’s PET Center.
The researchers will use the information they gather about the neurobiology of opioid abuse to develop new interventions for opioid use disorder. Initial research will focus on opioid receptors in opioid sensitivity, addiction and suicide, as well as on the identification of genetic differences associated with the disorder, which will enable a precision medicine approach to diagnosis and treatment of patients.
More articles on opioids:
‘Nontraditional strategies’ needed to address fentanyl overdoses, researchers say
University Hospitals among 4 winners of Ohio Opioid Tech Challenge
Pennsylvania hospital association launches opioid action collaborative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
